TD Asset Management Inc Sells 1,583 Shares of CME Group Inc. $CME

TD Asset Management Inc lessened its stake in shares of CME Group Inc. (NASDAQ:CME) by 0.4% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 398,058 shares of the financial services provider’s stock after selling 1,583 shares during the period. TD Asset Management Inc’s holdings in CME Group were worth $109,713,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of CME. Wayfinding Financial LLC bought a new stake in CME Group in the first quarter valued at approximately $25,000. Webster Bank N. A. raised its stake in CME Group by 206.9% in the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after buying an additional 60 shares during the period. Cornerstone Planning Group LLC raised its stake in CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after buying an additional 55 shares during the period. Highline Wealth Partners LLC raised its stake in CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 43 shares during the period. Finally, Golden State Wealth Management LLC raised its stake in CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after buying an additional 98 shares during the period. Institutional investors own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on CME. Morgan Stanley upped their price objective on CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a research note on Wednesday, October 1st. UBS Group dropped their price objective on CME Group from $305.00 to $285.00 and set a “neutral” rating on the stock in a research note on Monday, September 8th. Jefferies Financial Group dropped their price objective on CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a research note on Friday, October 10th. Deutsche Bank Aktiengesellschaft decreased their target price on CME Group from $276.00 to $266.00 and set a “hold” rating on the stock in a research report on Thursday, October 9th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. Seven investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $283.71.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard bought 262 shares of CME Group stock in a transaction on Thursday, September 25th. The shares were purchased at an average price of $265.19 per share, with a total value of $69,479.78. Following the acquisition, the director owned 258,459 shares in the company, valued at $68,540,742.21. This trade represents a 0.10% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. This represents a 4.76% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 13,043 shares of company stock worth $3,527,956. 0.30% of the stock is owned by corporate insiders.

CME Group Trading Down 1.5%

Shares of NASDAQ:CME opened at $267.18 on Wednesday. The company has a market capitalization of $96.29 billion, a P/E ratio of 25.86, a P/E/G ratio of 6.23 and a beta of 0.41. CME Group Inc. has a 1 year low of $213.94 and a 1 year high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The business’s 50 day simple moving average is $268.22 and its 200 day simple moving average is $271.32.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.56 earnings per share. On average, research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio is currently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.